Jiangsu Nannong High-tech Co., Ltd., Nannong High-tech Co., Ltd., a service provider of livestock and poultry disease diagnosis and epidemic prevention and control, and healthy breeding solutions, is a high-tech enterprise specializing in the research and development, production, operation and service of veterinary biological products
Jiangsu Nannong High-tech Co., Ltd. is a high-tech enterprise specializing in the research and development, production, operation and service of veterinary biological products, which is mainly invested and established by Nanjing Agricultural University and Jiangyin Xinjinnan Investment and Development Co., Ltd. in accordance with the modern enterprise system.
Founded in 2000, the company has built two production workshops and 8 production lines for live vaccines and inactivated vaccines that have passed the GMP acceptance of the Ministry of Agriculture, has two series of livestock and poultry with a total of 23 products, and has an annual production capacity of 10 billion live vaccines (heads) and 500 million ml of inactivated vaccines. There are 257 employees, 72% of whom have a college degree or above, including 2 members of the Veterinary Pharmacopoeia Committee of the Ministry of Agriculture, 1 postdoctoral fellow, 5 doctors, 26 scientific and technological personnel engaged in new product research and development, 17 masters, and 6 senior professional titles.
In 2009, the company established the Jiangsu Provincial Animal Disease Prevention and Control Bioengineering Technology Research Center, hired Academician Liu Xiufan of Yangzhou University and Professor Jiang Ping of Nanjing Agricultural University as the chief scientist of the Engineering Center. double inactivated vaccine for infectious gastroenteritis; The core products of chicken Newcastle disease and avian influenza (H9 subtype) disease prevention and control are chicken Newcastle disease live vaccine (N79), chicken Newcastle disease (A-VII.) inactivated vaccine, avian influenza (H9) series inactivated vaccine, and has 3 patents, including 1 independent invention patent, and has obtained 4 national new veterinary drug certificates: "porcine circovirus type 2 inactivated vaccine", "porcine reproductive and respiratory syndrome live vaccine (R98 strain), chicken Newcastle disease, infectious bronchitis, avian influenza (H9 subtype) triple inactivated vaccine" and "chicken Newcastle disease, Infectious bronchitis, egg-reducing syndrome, avian influenza (H9 subtype) quadruple inactivated vaccine", etc.
The company adheres to the business philosophy of "new technology, heart service, new benchmark" and the enterprise spirit of "standing by virtue, innovation and excellence, sincerity and prosperity, and win-win", and builds an expert service team with comprehensive technology, excellent business and high credibility, advocates healthy breeding and scientific seedlings, and provides fast and accurate disease diagnosis and epidemic prevention and control, and healthy breeding programs for the majority of farmers; At the same time, we will continue to speed up the research and development of new products, new technologies and new processes, transform scientific and technological achievements into productivity at the first time, and continuously introduce more new technologies and new products urgently needed by the livestock and poultry breeding industry, so as to provide high-quality services for the modern livestock and poultry breeding industry with the spirit of pioneering and innovating and pursuing excellence.
